Executive Management

Oleg Movchan is the Chief Executive Officer of Enfusion. As an Enfusion founding investor, Mr. Movchan played a key role in Enfusion’s early product and technology evolution and was deeply involved in scaling the business over the years. Mr. Movchan has been an Enfusion client at several investment firms and joined the Enfusion Board of Directors in 2021 after serving on the Board of Managers since 2009.

Mr. Movchan’s experience in the asset management, investment banking, and operating industries spans more than 27 years across both public and private capital markets. He previously served as the Chief Risk Officer and Head of Risk Management for multiple asset management firms overseeing hedge funds, fund-of-funds and other investment vehicles, including UBS Global Asset Management, Ritchie Capital Management, Alexandra Investment Management, and Attalus Capital. He is a Founder and Managing Partner of Gimel Tech Ventures, a private equity and venture capital investment platform specializing in applications of technology in financial services, cyber security, real estate, and healthcare.

Additionally, Mr. Movchan is a founding investor in Revolution Global, a vertically integrated consumer packaged goods operating platform. During his tenure (from inception in 2014 through 2021), Mr. Movchan held various senior leadership roles, including Chief Investment Officer, Chief Strategy Officer, Deputy CEO, and Board Member.

A graduate of the General Management Program from Aresty Institute of Executive Education at the University of Pennsylvania’s Wharton School, Mr. Movchan earned a MS in Financial Mathematics and an MBA in Analytic Finance from the University of Chicago. He received a MS in Applied Mathematics and Physics from Kharkov State University, Ukraine. Mr. Movchan also holds a CFA designation.

Neal Pawar currently serves as Enfusion’s Chief Operating Officer and is a member of the firm’s Executive Committee. In his role, he oversees the Revenue, Product, Engineering, and Client Services organizations at Enfusion.

“Enfusion was designed by engineers and investors who grew up in the asset management industry; practitioners who had the vision to build a Software-as-a-Service platform from the ground up. As someone who has spent the majority of his career leading engineering and operations teams for some of the largest asset managers in the world, I could immediately see a level of client understanding and empathy that I simply haven’t seen in other platforms.”

A computer scientist by training, Neal has spent nearly 30 years in the financial services industry in a number of leadership roles. Neal has held senior operating roles on the buy-side of investment management, including as a Partner and CTO at quantitative firms D. E. Shaw & Co, and AQR Capital, as well as global operating roles as CIO of UBS Wealth Management and Group CIO of Deutsche Bank. Most recently he was COO and interim CEO of Qontigo, a provider of financial intelligence tools and indices for investment managers.

Neal is a member of the Board of Directors at CAIS group and a strategic advisor to Talos, a digital asset trading firm. He holds a B.S. in Computer Science from Brown University.

Bronwen Bastone is Chief People Officer at Enfusion. She is responsible for rapidly scaling Enfusion’s approach to human resources. She has 20 years of experience in HR leadership roles across multiple industries, including institutional finance.

Previously, she led HR at Exos, a B2B institutional finance platform. She has also held senior HR roles at Knight Capital, Merrill Lynch, Cushman Wakefield, Brookfield Asset Management, and Southwest Power Pool. She holds an MBA from the University of Technology, Sydney (Australia).

Bradley Herring joined Enfusion as Chief Financial Officer in 2022 with more than 30 years of experience in finance leadership.

Prior to Enfusion, Herring served as Chief Financial Officer for multiple fintech companies, including Shift4 Payments, LLC, Elavon, Inc., and the digital banking group of Fiserv. Herring holds a Bachelor of Arts degree in Management and Economics and a Masters of Business Administration from Georgia Institute of Technology Scheller College of Business.

Matt Campobasso serves as Enfusion's General Counsel and Corporate Secretary. Starting with Enfusion in 2020, Matt spends his time overseeing Enfusion’s legal operations, which involves securing the company’s interests and understanding and managing legal risk at all levels of the company, as well as both internal and external to our business. A firm believer in the ethos that a problem prevented is better than a problem solved, Matt is the primary legal adviser to Enfusion's business, including as to Enfusion's Board of Directors, Chief Executive Officer, and across executive leadership.

“Enfusion is unlike any other company that I have ever worked for or with. Our collective commitment to our clients, our shareholders, and to each other is what distinguishes us from our competitors and beyond. During my time here, I have yet to encounter an issue or problem that wasn’t capable of being solved through collaboration and critical thinking by the incredibly smart, committed, and creative professionals that I am proud to call my colleagues.”

Matt began his legal career as a criminal prosecutor. Following that, he spent 11 years at a global law firm, first as an Associate and then as a Partner, in the firm's complex commercial litigation practice group. Later he served as General Counsel for a private consulting firm that was eventually acquired by IBM.

Matt graduated from the University of Illinois Urbana-Champaign in May 2000 with a Bachelor of Science in Psychology. He received his Juris Doctorate from the University of Illinois Chicago School of Law in May 2006.

Dan Groman is Chief Technology Officer at Enfusion where he leads Enfusion’s Engineering Infrastructure and Security teams. Groman joined Enfusion in 2016 and has led the expansion of Enfusion’s SaaS native platform, which has enabled growth into new client segments. He was appointed to his current role in July 2021.

Prior to joining Enfusion, Groman served as an engineer at CME Group. He began his career working with insurance companies, asset managers and hedge funds in product and middle/back-office operating roles.

Groman holds a bachelor’s degree in Economics from the University of Maryland and a master’s degree in Computer Science from DePaul University.

Dan Jacobs serves as Chief Revenue Officer at Enfusion where he oversees all revenue generation and marketing efforts. He has been with Enfusion for more than 12 years, having served in a variety of roles including as an Implementation and Business Development Specialist and as the Global Head of Business Development, responsible for strategic initiatives that drive sales and new business, before moving onto his current role.

Jacobs has more than 18 years of experience in the investment management industry, including five years spent at WR Managed Holdings, where he served as Vice President of Risk Management.

Jacobs holds a bachelor's degree from Georgetown University.

Chris Sturhahn joined Enfusion as Chief Product Officer in 2024 and leads all product development efforts.

“At Enfusion I see the opportunity to do something truly unique and meaningful for the asset management industry. Managing portfolios and the trade lifecycle are at the very heart of the investment process, and Enfusion’s systems allow our clients to react quickly and efficiently to the latest trends in the market. The technology platform we have is an ideal vehicle to be able to deliver the insights and information needed in real-time so that everyone, from portfolio managers to operations teams, is always up-to-date.”

Prior to Enfusion, Chris served as Chief Product Officer of Analytics at SimCorp, where he led the product and research teams for the Axioma business. Earlier in his career Chris led teams in Analytics and Quantitative solutions at Blackrock, as well as held senior roles at Bloomberg and Barclays, where he worked on the well-known system POINT, part of their Fixed Income Analytics and Indices business.

Chris is a CFA charterholder and holds a bachelor's degree in Computer Science from the University of Illinois at Urbana-Champaign and a Masters of Business Administration from NYU Stern.